'I haven't discussed anything with anyone': lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for substance use disorder
Van Ngoc, Pauline; Ceuterick, Melissa; Belche, Jean Lucet al.
2024 • In International Journal of Qualitative Studies on Health and Well-Being, 19 (1), p. 2424013
I haven t discussed anything with anyone lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for subs.pdf
Benzodiazepines; Z-drugs; interpretative phenomenological analysis; patient experience; qualitative research
Abstract :
[en] [en] INTRODUCTION: Treatment for substance use disorder (SUD) to benzodiazepine receptor agonists (BZRA) can be challenging and lengthy. BZRA are prescribed for anxiety and insomnia, and though guidelines recommend an initial prescription duration of one to four weeks, this is frequently longer. Understanding the multiple challenges associated with withdrawing from BZRA and exploring the nuance and complexities from the patient's perspective is crucial.
METHODS: In this study, we explore the experiences of SUD to BZRA with nineteen users, who have subsequently either stabilized, reduced, or discontinued their usage. The data were analysed using Interpretative Phenomenological Analysis.
FINDINGS: Our study identified five key themes regarding the long-term use of BZRA which address inadequate patient information, strict adherence to prescribed medication, minimal involvement in cessation plans, respecting patient readiness for tapering and personalized tapering approaches.
CONCLUSION: These findings indicate that patients' blind trust in their providers can prevent them from voicing concerns, highlighting the importance of an authentic and collaborative relationship between the patient and healthcare provider, while respecting patient autonomy. The goal-oriented care approach could improve BZRA management by aligning treatment with individual goals, enhancing satisfaction, and addressing the complexities of long-term use and withdrawal.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Van Ngoc, Pauline ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale
Ceuterick, Melissa ; Hedera, Department of Sociology, Faculty of Political and Social Sciences, Ghent University, Ghent, Belgium
Belche, Jean Luc ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale
Scholtes, Béatrice ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale
Language :
English
Title :
'I haven't discussed anything with anyone': lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for substance use disorder
Publication date :
December 2024
Journal title :
International Journal of Qualitative Studies on Health and Well-Being
Anthierens, S., Habraken, H., Petrovic, M., Deveugele, M., De Maeseneer, J., & Christiaens, T., (2007). First benzodiazepine prescriptions: Qualitative study of patients’ perspectives. Canadian Family Physician, 53(7), 1200–12.
Anthierens, S., Pasteels, I., Habraken, H., Habraken, H., Steinberg, P., Declercq, T., Christiaens, T., & Christiaens, T., (2010). Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: Family physicians’ attitudes toward benzodiazepine prescribing. Canadian Family Physician, 56(11), e398–406.
Ashton, H., (1991). Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment, 8(1–2), 19–28. https://doi.org/10.1016/0740-5472(91)90023-4
Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P.-M., & Eschalier, A., (2009). Benzodiazepine dependence: Focus on withdrawal syndrome. Annales Pharmaceutiques Françaises, 67(6), 408–413. https://doi.org/10.1016/j.pharma.2009.07.001
Axinn, W. G., Chardoul, S., Gatny, H., Ghimire, D. J., Smoller, J. W., Zhang, Y., & Scott, K. M., (2020). Using life history calendars to improve measurement of lifetime experience with mental disorders. Psychological Medicine, 50(3), 515–522. https://doi.org/10.1017/S0033291719000394
Bacon, I., McKay, E., Reynolds, F., & McIntyre, A., (2020). The lived experience of codependency: An interpretative phenomenological analysis. International Journal of Mental Health and Addiction, 18(3), 754–771. https://doi.org/10.1007/s11469-018-9983-8
Bergqvist, A., Crepaz-Keay, D., & Wilde, A., (2023). Introduction: What is the role of lived experience in research?Royal Institute of Philosophy Supplement, 94, 1–14. https://doi.org/10.1017/S1358246123000292
Berntsen, G., Høyem, A., Lettrem, I., Ruland, C. M., Rumpsfeld, M., & Gammon, D., (2018). A person-centered integrated care quality framework, based on a qualitative study of patients’ evaluation of care in light of chronic care ideals. BMC Health Services Research, 18(1), 1–15. https://doi.org/10.1186/s12913-018-3246-z
Boeykens, D., Boeckxstaens, P., De Sutter, A., Lahousse, L., Pype, P., De Vriendt, P., Van de Velde, D., & Prazeres, F., (2022). Goal-oriented care for patients with chronic conditions or multimorbidity in primary care: A scoping review and concept analysis. PLOS ONE, 17(2), e0262843–e0262843. https://doi.org/10.1371/journal.pone.0262843
Carey, T. A., & MacGregor, M., (2019). Understanding why youth in remote Australia use alcohol in the ways that they do. The Australian Journal of Rural Health, 27(5), 380–385. https://doi.org/10.1111/ajr.12523
Carrie, M. S., & Wright, S. L., (2022). Surviving benzodiazepines: A patient’s and clinician’s perspectives. Advances in Therapy, 39(5), 1871–1880. https://doi.org/10.1007/s12325-022-02055-y
Centre Belge d’Informations Pharmacothérapeutique, C. (n.d.). Hypnotiques, sédatifs, Anxiolitiques. https://www.cbip.be/fr/chapters/11?frag=7476
Ceuterick, M., Christiaens, T., Creupelandt, H., & Bracke, P., (2021). Perception, habitual use and cessation of BENZOdiazepines: A multi-method NETnography (p. 104) [Final report]. Belgian Science Policy Office. http://www.belspo.be/belspo/drugs/project_docum_nl.stm#DR81
Ceuterick, M., Van Ngoc, P., Bracke, P., & Scholtes, B., (2023). From prescribing dilemma to knowledge in practice: The ontological politics of benzodiazepines and Z-drugs. Social Science & Medicine, 339(1982), 116358. https://doi.org/10.1016/j.socscimed.2023.116358
Chahal, K., Glass, M., Falk, J., Singer, A., & Leong, C., (2023). Patient values and preferences regarding communicating risk versus benefit of benzodiazepine initiation: A cross‐sectional survey study. Health Science Reports, 6(12), e1597. https://doi.org/10.1002/hsr2.1597
Chorlton, E., Smith, I., & Jones, S. A., (2015). Understanding how people who use illicit drugs and alcohol experience relationships with psychiatric inpatient staff. Social Psychiatry & Psychiatric Epidemiology, 50(1), 51–58. https://doi.org/10.1007/s00127-014-0920-2
Cloetens, H., Declercq, T., Habraken, H., Callens, J., & Van Gastel, A., (2018). First-line treatment of sleep disorders and insomnia in adults. https://ebpnet.be/fr/ebsources/250
Cook, J. M., Biyanova, T., Thompson, R., & Coyne, J. C., (2007). Older primary care patients’ willingness to consider discontinuation of chronic benzodiazepines. General Hospital Psychiatry, 29(5), 396–401. https://doi.org/10.1016/j.genhosppsych.2007.07.001
Coteur, K., Henrard, G., Schoenmakers, B., Laenen, A., Van den Broeck, K., De Sutter, A., Anthierens, S., Devroey, D., Kacenelenbogen, N., Offermans, A.-M., & Van Nuland, M., (2022a). Blended care to discontinue BZRA use in patients with chronic insomnia disorder: A pragmatic cluster randomized controlled trial in primary care. Sleep, 46(4). https://doi.org/10.1093/sleep/zsac278
Coteur, K., Mamouris, P., Vaes, B., Nuland, V., Marc, M., Schoenmakers, Catharina, B., & Schoenmakers, B., (2022b). Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study. Frontiers in Public Health, 10, 10. https://doi.org/10.3389/fpubh.2022.1014734
Dawood, R., & Done, J., (2021). An interpretative phenomenological analysis of service users’ experiences in a psychosocial addictions intervention. Psychology & Psychotherapy: Theory, Research & Practice, 94(2), 307–321. https://doi.org/10.1111/papt.12296
Dodds, T. J., (2017). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19(2). https://doi.org/10.4088/PCC.16r02037
Fixsen, A., (2016). “I’m not waving, I’m drowning” an autoethnographical exploration of biographical disruption and reconstruction during recovery from prescribed benzodiazepine use. The Qualitative Health Research, 26(4), 466–481. https://doi.org/10.1177/1049732315576496
Freedman, D., Thornton, A., Camburn, D., Alwin, D., & Yound DeMarco, L., (1988). The life history calendar: A technique for collecting retrospective data. Sociological Methodology, 18, 37–68. https://doi.org/10.2307/271044
Institut national d’assurance maladie-invalidité. (n.d.). Programme de sevrage aux benzodiazépines et produits apparentés. Institut national d’assurance maladie-invalidité. Retrieved July11, 2024, fromhttps://www.inami.fgov.be/fr/themes/soins-de-sante-cout-et-remboursement/les-prestations-de-sante-que-vous-rembourse-votre-mutualite/prestations-de-soins-individuelles/honoraires-prix-et-remboursements/honoraires-prix-et-remboursements-programme-de-sevrage-aux-benzodiazepines-et-produits-apparentes-z-drug
Kapadia, N., Fox, D., Rowlands, G., & Ashworth, M., (2007). Developing primary care services for high-dose benzodiazepine-dependent patients: A consultation survey. Drugs-Education Prevention and Policy, 14(5), 429–442. https://doi.org/10.1080/09687630601108256
Kassai, S., Pintér, J. N., Rácz, J., Böröndi, B., Tóth-Karikó, T., Kerekes, K., & Gyarmathy, V. A., (2017). Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis. Harm Reduction Journal, 14(1), 9. https://doi.org/10.1186/s12954-017-0138-1
Kiridis, S., Sawchik, J., Maenhaut, N., Sabbe, M., Wuillaume, F., & Hamdani, J., (2022). Survey on the use of benzodiazepines and Z-drugs to treat insomnia in Belgium. Federal Agency for Medicines and Health Products. https://www.fagg.be/sites/default/files/BZRA_study_report_2020_DEF_21.06.2022_0.pdf
Kurko, T., Saastamoinen, L. K., Tähkäpää, S., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M., & Hietala, J., (2015). Long-term use of benzodiazepines: Definitions, prevalence and usage patterns–a systematic review of register-based studies. European Psychiatry, 30(8), 1037–1047. https://doi.org/10.1016/j.eurpsy.2015.09.003
Lader, M., (1999). Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified?European Neuropsychopharmacology, 9, S399–S405. https://doi.org/10.1016/s0924-977x(99)00051-6
Lader, M., (2011). Benzodiazepines revisited-will we ever learn?Addiction, 106(12), 2086–2109. https://doi.org/10.1111/j.1360-0443.2011.03563.x
Lader, M., (2014). Benzodiazepine harm: How can it be reduced?British Journal of Clinical Pharmacology, 77(2), 295–301. https://doi.org/10.1111/j.1365-2125.2012.04418.x
Liebrenz, M., Schneider, M., Buadze, A., Gehring, M.-T., Dube, A., Caflisch, C., & Alessi-Severini, S., (2015). High-dose benzodiazepine dependence: A qualitative study of patients’ perceptions on initiation, reasons for use, and obtainment. PLOS ONE, 10(11), e0142057. https://doi.org/10.1371/journal.pone.0142057
Linsky, A., & Zimmerman, K. M., (2018). Provider and system-level barriers to Deprescribing: Interconnected problems and solutions. Public Policy & Aging Report, 28(4), 129–133. https://doi.org/10.1093/ppar/pry030
Lutaud, R., Cortaredona, S., Delorme, L., Peretti-Watel, P., Mirouse, J., Borg, M., Cattaneo, L., Thery, D., Gentile, G., Pradier, C., Irit, T., Brouqui, P., Tardieu, S., Carles, M., & Gentile, S., (2024). COVID-19 patient experiences in prehospital pathways: A processual approach using life-events calendar method and state sequence analysis shows detrimental delays. Family Medicine and Community Health, 12(1), e002447. https://doi.org/10.1136/fmch-2023-002447
Lynch, T., Ryan, C., & Cadogan, C. A., (2021). ‘I just thought that it was such an impossible thing’: A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the theoretical domains framework. Health Expectations, 25(1), 355–365. https://doi.org/10.1111/hex.13392
Lynch, T., Ryan, C., Huff, C., Foster, D. E., & Cadogan, C., (2024). ‘We need more support and doctors that understand the process of tapering … ’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use. Health Expectations, 27(1), e13962. https://doi.org/10.1111/hex.13962
Mold, J., (2017). Goal-directed health care: Redefining health and health care in the Era of value-based care. Cureus. https://doi.org/10.7759/cureus.1043
Nelson, I. A., (2010). From quantitative to qualitative: Adapting the life history calendar method. Field Methods, 22(4), 413–428. https://doi.org/10.1177/1525822X10379793
Oldenhof, E., Mason, T., Anderson-Wurf, J., & Staiger, P. K., (2021). Role of the prescriber in supporting patients to discontinue benzodiazepines: A qualitative study. British Journal of General Practice, 71(708), e517–e527. https://doi.org/10.3399/bjgp.2020.1062
Park, M., Fudjack, S., Soucie, K., & LaBelle, O., (2023). Participant experiences in student recovery programs in Canada: An interpretative phenomenological analysis. Alcoholism Treatment Quarterly, 41(3), 338–361. https://doi.org/10.1080/07347324.2023.2204819
Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R., (2022). Experiences with benzodiazepine use, tapering, and discontinuation: An internet survey. Therapeutic Advances in Psychopharmacology, 12, 204512532210823. https://doi.org/10.1177/20451253221082386
Reuben, D. B., & Tinetti, M. E., (2012). Goal-oriented patient care—an alternative health outcomes paradigm. New England Journal of Medicine, 366(9), 777–779. https://doi.org/10.1056/nejmp1113631
Ribeiro, P. R. D. S., & Schlindwein, A. D., (2021). Benzodiazepine deprescription strategies in chronic users: A systematic review. Family Practice, 38(5), 684–693. https://doi.org/10.1093/fampra/cmab017
Sake, F.-T.-N., Wong, K., Bartlett, D. J., & Saini, B., (2019). Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs. Research in Social & Administrative Pharmacy, 15(11), 1317–1325. https://doi.org/10.1016/j.sapharm.2018.12.007
Salter, C., Shiner, A., Lenaghan, E., Murdoch, J., Ford, J. A., Winterburn, S., & Steel, N., (2019). Setting goals with patients living with multimorbidity: Qualitative analysis of general practice consultations. British Journal of General Practice, 69(684), e479–e488. https://doi.org/10.3399/bjgp19X704129
Seddon, J., Friedrich, C., Wadd, S., Dicks, D., Scott, S., Robinson, A., & Walker, C., (2024). Improving patient experience for people prescribed medicines with a risk of dependence or withdrawal: Co-designed solutions using experience based co-design. BMC Primary Care, 25(1), 17. https://doi.org/10.1186/s12875-023-02253-9
Sirdifield, C., Chipchase, S., Owen, S., & Siriwardena, A. N., (2017). A systematic review and meta-synthesis of patients’ experiences and perceptions of seeking and using benzodiazepines and Z-Drugs: Towards safer prescribing. The Patient: Patient-Centered Outcomes Research, 10(1), 1–15. https://doi.org/10.1007/s40271-016-0182-z
Smith, J. A., & Nizza, I. E., (2021). Essentials of interpretative phenomenological analysis. American Psychological Association.
Socias, I., Leiva, A., Pombo-Ramos, H., Bejarano, F., Sempere-Verdú, E., Rodríguez-Rincón, R. M., Fiol, F., Mengual, M., Ajenjo-Navarro, A., Do Pazo, F., Mateu, C., Folch, S., Alegret, S., Coll, J. M., Martín-Rabadán, M., & Vicens, C., (2021). Evaluating the implementation of a multicomponent intervention consisting of education and feedback on reducing benzodiazepine prescriptions by general practitioners: BENZORED hybrid type I cluster randomized controlled trial. International Journal of Environmental Research and Public Health, 18(15), 7964. https://doi.org/10.3390/ijerph18157964
Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S., (2014). Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Internal Medicine, 174(6), 890–898. https://doi.org/10.1001/jamainternmed.2014.949
Van Ngoc, P., Ceuterick, M., Belche, J.-L., & Scholtes, B., (2024). Professionals’ treatment goals for long-term benzodiazepine and Z-drugs management: A qualitative study. BJGP Open. https://doi.org/10.3399/BJGPO.2023.0034
Vermeer, W. M., Bakker, R. M., Kenter, G. G., Stiggelbout, A. M., & Ter Kuile, M. M., (2016). Cervical cancer survivors’ and partners’ experiences with sexual dysfunction and psychosexual support. Supportive Care in Cancer, 24(4), 1679–1687. https://doi.org/10.1007/s00520-015-2925-0
Wagstaff, C., Davis, A., Jackson McConnel, E., MacDonald, M., Medlyn, A., & Pillon, S., (2023). Experiences of homeless people who use psychoactive substances: An interpretative phenomenological study. Drugs, Habits and Social Policy, 24(3), 205–219. https://doi.org/10.1108/DHS-04-2023-0012
Wangensteen, T., & Hystad, J., (2022). Trust and collaboration between patients and staff in SUD treatment: A qualitative study of patients’ reflections on inpatient SUD treatment four years after discharge. Nordic Studies on Alcohol & Drugs, 39(4), 418–436. https://doi.org/10.1177/14550725221082366
